Shares of Tilray Inc. (TLRY) surged 5.23% in Sunday's extended trading session, following a highly positive analyst report. The cannabis company's stock received a significant boost after TD Cowen analyst Robert Moskow reiterated his Buy rating and dramatically increased the price target.

In a notable move, Moskow raised his price target for Tilray from $0.80 to $2.50, representing a substantial increase of over 200%. This upgrade reflects growing confidence in Tilray's growth potential and strategic market positioning within the cannabis industry.

While specific details of Moskow's analysis were not provided, the magnitude of the price target increase suggests a bullish outlook on Tilray's future prospects. Investors appear to be reacting positively to this vote of confidence from a respected industry analyst, driving the stock's after-hours rally.